Results 191 to 200 of about 33,686 (288)

Innovation in technologies for monitoring lung function in patients with respiratory disease. [PDF]

Breathe (Sheff)
Toumpanakis D, Usmani OS.
europepmc   +1 more source

UiO‐66 metal–organic frameworks in biomedicine: From structural tunability to bioimaging, photodiagnostics, and photodynamic cancer therapy

FEBS Open Bio, EarlyView.
UiO‐66(Zr) metal–organic frameworks are chemically stable, biocompatible, and highly tunable nanomaterials. Their modular structure enables controlled drug delivery, multimodal bioimaging, and light‐activated photodynamic therapy, supporting integrated diagnostic and therapeutic (theranostic) applications in cancer and biomedical research.
Veronika Huntošová, Grigorii Rakhalskii, Miroslav Almáši   +2 more
wiley   +1 more source

Mental Health Nurses' Enforcement of Involuntary Care in Inpatient Settings: A Meta-Ethnography. [PDF]

Int J Ment Health Nurs
Molloy L, Beckett P, Chidarikire S, Cutler N, Isobel S, Murphy G, Zugai J.   +6 more
europepmc   +1 more source

Developing European Legal Information Markets based on Government Information [PDF]

, 2004
Mc Cullagh, Karen
core  

Prognostic Impact of European LeukemiaNet Genetic Risk Stratification System in Adult Patients With Acute Myeloid Leukemia

Aging and Cancer, EarlyView.
This study aimed to evaluate the prognostic value of ELN2017 in predicting survival outcomes and to assess the impact of clinical and molecular factors such as age, FLT3 and NPM1 mutations, and allogeneic hematopoietic stem cell transplantation (allo‐HSCT).
Mobina Shrestha, Bishwas Mandal, Vishal Mandal, Asis Shrestha, Amir Babu Shrestha   +4 more
wiley   +1 more source

Long‐Term Follow‐Up of Chemotherapy‐Associated Biological Aging in Women With Early Breast Cancer

Aging and Cancer, EarlyView.
Women threated with adjuvant chemotherapy for early breast cancer have sustained long‐term increase in p16INK4a,, a robust marker of cell senescence, suggesting a chemotherapy‐associated age acceleration. p16INK4a as well as other biomarkers may identify patients at greatest risk for senescence‐related diseases of aging.
Hyman B. Muss, Alexis C. Wardell, Allison M. Deal, Kirsten A. Nyrop, Allison Ross, Yara G. Abdou, Jeffrey D. Aldrich, Lisa A. Cary, E. Claire Dees, Katherine E. Reeder‐Hayes, Emily M. Ray, Natalia Mitin, Denis Tsygankov   +12 more
wiley   +1 more source

Improving specialist palliative care discharges from hospitals and hospices to community settings: a qualitative interview study of the communication experiences of patients, carers, and primary care professionals. [PDF]

BMC Palliat Care
Weetman K, Grimley C, Bailey C, Bernstein CJ, Dale J, Fitch A, Mitchell S, Tiwana R, MacArtney JI.   +8 more
europepmc   +1 more source

Public Procurement and Cohesion Policy [PDF]

, 2012
Nyikos, Györgyi, Tátrai, Tünde
core  

Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham, Sahana Sathyanarayana, Charlotte B. Stewart, Robyn Iredale, Victoria Foster, Debra Galley, Mark Baker, Nicola Pavese   +7 more
wiley   +1 more source

Invasive ventilation and mortality in critically ill nonagenarians: a retrospective cohort study. [PDF]

Eur J Med Res
Haar M, Gleibs F, Hertrich AC, Müller J, Daniels R, Theile P, Kluge S, Roedl K.   +7 more
europepmc   +1 more source